outcome assessment

Response to: ‘Correspondence on ‘EULAR recommendations for a core data set for pregnancy registries in rheumatology” by De Cock et al
Yvette Meissner, Rebecca Fischer-Betz, Angela Zink, Anja Strangfeld

Annals of the Rheumatic Diseases Nov 2020, annrheumdis-2020-219478; DOI: 10.1136/annrheumdis-2020-219478
Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the TARA trial
Elise van Mulligen, Angelique E Weel, Tjallingius Martijn Kuijper, N H A M Denissen, Andreas H Gerards, Mike H de Jager, Wai-Kwan Lam-Tse, J M Hazes, Annette van der Helm-van Mil, Pascal Hendrik Pieter de Jong, Jolanda J Luime

Annals of the Rheumatic Diseases Dec 2020, 79 (12) 1550-1556; DOI: 10.1136/annrheumdis-2020-217528
Response to ‘Correspondence on ‘Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study’’ by Zheng et al
Dimitrios A Pappas, Gregory St John, Carol J Etzel, Stefano Fiore, Taylor Blachley, Toshio Kimura, Rajeshwari Punekar, Kelechi Emeanuru, Jeannie Choi, Susan Boklage, Joel M Kremer

Annals of the Rheumatic Diseases Nov 2020, annrheumdis-2020-218907; DOI: 10.1136/annrheumdis-2020-218907
Declining in-hospital mortality gap between systemic lupus erythematosus (SLE) and non-SLE hospitalisations: a national study
Jasvinder A Singh, John D Cleveland

Annals of the Rheumatic Diseases Nov 2020, annrheumdis-2020-218386; DOI: 10.1136/annrheumdis-2020-218386
EULAR recommendations for a core data set for pregnancy registries in rheumatology
Yvette Meissner, Rebecca Fischer-Betz, Laura Andreoli, Nathalie Costedoat-Chalumeau, Diederik De Cock, Radboud J E M Dolhain, Frauke Forger, Doreen Goll, Anna Molto, Catherine Nelson-Piercy, Rebecca Özdemir, Luigi Raio, Sebastian Cruz Rodríguez-García, Savino Sciascia, Marianne Wallenius, Astrid Zbinden, Angela Zink, Anja Strangfeld

Annals of the Rheumatic Diseases Oct 2020, annrheumdis-2020-218356; DOI: 10.1136/annrheumdis-2020-218356
Patient global assessment to define remission in rheumatoid arthritis:quo vadis?
Maarten Boers

Annals of the Rheumatic Diseases Nov 2020, annrheumdis-2020-218802; DOI: 10.1136/annrheumdis-2020-218802
Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response: efficacy and safety in patients with rheumatoid arthritis
Roy M Fleischmann, Ricardo Blanco, Stephen Hall, Glen T D Thomson, Filip E Van den Bosch, Cristiano Zerbini, Louis Bessette, Jeffrey Enejosa, Yihan Li, Yanna Song, Ryan DeMasi, In-Ho Song

Annals of the Rheumatic Diseases Nov 2020, annrheumdis-2020-218412; DOI: 10.1136/annrheumdis-2020-218412
Response to: ‘Correspondence on ‘Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases’’ by Schulze-Koops et al
Dalifer Dayanira Freites Nuñez, Leticia Leon, Arkaitz Mucientes, Luis Rodriguez-Rodriguez, Judit Font Urgelles, Alfredo Madrid García, Jose Ignacio Colomer, Juan A Jover, Benjamín Fernandez-Gutierrez, Lydia Abasolo

Annals of the Rheumatic Diseases Oct 2020, annrheumdis-2020-219230; DOI: 10.1136/annrheumdis-2020-219230
Response to ‘Neither earlier not late tocilizumab improved outcomes in the intensive care unit patients with COVID-19 in a retrospective cohort study’ by Moiseev et al
Sofia Ramiro, Robert B M Landewé, Rémy Mostard

Annals of the Rheumatic Diseases Oct 2020, annrheumdis-2020-219295; DOI: 10.1136/annrheumdis-2020-219295
Towards consensus in defining and handling contextual factors within rheumatology trials: an initial qualitative study from an OMERACT working group
Sabrina Mai Nielsen, Marianne Uggen Rasmussen, Maarten Boers, Danielle A van der Windt, Maarten de Wit, Thasia G Woodworth, Caroline A Flurey, Dorcas Beaton, Beverley Shea, Reuben Escorpizo, Daniel E Furst, Josef S Smolen, Karine Toupin-April, Annelies Boonen, Marieke Voshaar, Torkell Ellingsen, George A Wells, Barnaby C Reeves, Lyn March, Peter Tugwell, Robin Christensen

Annals of the Rheumatic Diseases Oct 2020, annrheumdis-2020-217895; DOI: 10.1136/annrheumdis-2020-217895

Main menu

outcome assessment

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

outcome assessment

Pages